News | March 21, 2026
Bristol Myers Squibb scores major win with new Opdivo nods for Hodgkin Lymphoma in US, EU
These approvals represent a defining moment for people living with classical Hodgkin Lymphoma
These approvals represent a defining moment for people living with classical Hodgkin Lymphoma
RSM01, a preventive treatment targeting respiratory syncytial virus (RSV), was licensed earlier this month from the Gates Medical Research Institute
The facility features 2,176 high-performance GPUs across the US and Europe
The Taipei facility boasts 10 GMP API production lines, with a total reactor volume exceeding 350,000 liters
COVIRIX Medical says its broad-spectrum antiviral portfolio has already shown positive virology results against key pandemic threats
The expanded ownership is expected to improve access to Cialis for millions of men in Asia affected by ED and BPH
Neupharma gains exclusive rights to develop and commercialize corticorelin for peritumoral brain edema
The new entity will operate with separate resources, funding, and operations, while BioNTech will contribute related rights and mRNA technologies to support its ambitious mission
The move comes as China rapidly expands its capabilities in the pharmaceutical sector, particularly in licensing and drug development
The expansion builds on Veristat’s work helping Chinese pharmaceutical firms such as Hansoh Pharma and CStone Pharmaceuticals
Subscribe To Our Newsletter & Stay Updated
